Anakinra Therapy for Non-cancer Inflammatory Diseases.

Although this was not the intent of the study, a highly significant reduction in osteoarthritis pain and improved joint function was reported by those treated with canakinumab compared to patients receiving placebo ( Ridker et al., 2017 ).

also in 132,142 other papers

Compared to the placebo-treated group, anakinra-treated patients exhibited improved functional status, but did not reach statistical significance ( Abbate et al., 2013 ).

also in 111,027 other papers